Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Controlled release dexamethasone implants in the round window niche for salvage treatment of idiopathic sudden sensorineural hearing loss.

Plontke SK, Glien A, Rahne T, Mäder K, Salt AN.

Otol Neurotol. 2014 Aug;35(7):1168-71. doi: 10.1097/MAO.0000000000000434.

2.

Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.

Plontke SK, Löwenheim H, Mertens J, Engel C, Meisner C, Weidner A, Zimmermann R, Preyer S, Koitschev A, Zenner HP.

Laryngoscope. 2009 Feb;119(2):359-69. doi: 10.1002/lary.20074.

PMID:
19172627
3.

Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.

Wu HP, Chou YF, Yu SH, Wang CP, Hsu CJ, Chen PR.

Otol Neurotol. 2011 Jul;32(5):774-9. doi: 10.1097/MAO.0b013e31821fbdd1.

PMID:
21646929
4.

Sudden sensorineural hearing loss: results of intratympanic steroids as salvage treatment.

Dispenza F, De Stefano A, Costantino C, Marchese D, Riggio F.

Am J Otolaryngol. 2013 Jul-Aug;34(4):296-300. doi: 10.1016/j.amjoto.2012.12.010. Epub 2013 Jan 26.

PMID:
23357592
5.

Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss.

Chou YF, Chen PR, Kuo IJ, Yu SH, Wen YH, Wu HP.

Laryngoscope. 2013 Sep;123(9):2264-9. doi: 10.1002/lary.23909. Epub 2013 Jun 26.

PMID:
23804460
6.
7.

Outcomes research analysis of continuous intratympanic glucocorticoid delivery in patients with acute severe to profound hearing loss: basis for planning randomized controlled trials.

Plontke S, Löwenheim H, Preyer S, Leins P, Dietz K, Koitschev A, Zimmermann R, Zenner HP.

Acta Otolaryngol. 2005 Aug;125(8):830-9.

PMID:
16158529
8.

Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.

Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF.

Laryngoscope. 2007 Jan;117(1):3-15. Review.

PMID:
17202923
9.

Effectiveness of systemic high-dose dexamethasone therapy for idiopathic sudden sensorineural hearing loss.

Egli Gallo D, Khojasteh E, Gloor M, Hegemann SC.

Audiol Neurootol. 2013;18(3):161-70. doi: 10.1159/000346938. Epub 2013 Feb 27.

PMID:
23446332
11.

Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss.

Park MK, Lee CK, Park KH, Lee JD, Lee CG, Lee BD.

Otolaryngol Head Neck Surg. 2011 Dec;145(6):1016-21. doi: 10.1177/0194599811418169. Epub 2011 Aug 4.

PMID:
21817157
12.

Daily short-term intratympanic dexamethasone treatment alone as an initial or salvage treatment for idiopathic sudden sensorineural hearing loss.

Kakehata S, Sasaki A, Futai K, Kitani R, Shinkawa H.

Audiol Neurootol. 2011;16(3):191-7. doi: 10.1159/000320269. Epub 2010 Oct 21.

PMID:
20962524
13.

Intratympanic and systemic steroids for sudden hearing loss.

Koltsidopoulos P, Bibas A, Sismanis A, Tzonou A, Seggas I.

Otol Neurotol. 2013 Jun;34(4):771-6. doi: 10.1097/MAO.0b013e31828bb567.

PMID:
23652330
14.

Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss.

Selivanova OA, Gouveris H, Victor A, Amedee RG, Mann W.

Otol Neurotol. 2005 Sep;26(5):890-5.

PMID:
16151334
15.

Steroid-based treatments for patients with total sudden sensorineural hearing loss.

Nakache G, Migirov L, Trommer S, Drendel M, Wolf M, Henkin Y.

Acta Otolaryngol. 2015 Sep;135(9):907-13. doi: 10.3109/00016489.2015.1034881. Epub 2015 Apr 10.

PMID:
25857447
16.

Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy.

Bae SC, Noh HI, Jun BC, Jeon EJ, Seo JH, Park SY, Kim JK, Lee DH, Oh JH, Park SN, Yeo SW.

Acta Otolaryngol. 2013 May;133(5):428-33. doi: 10.3109/00016489.2012.749520. Epub 2013 Jan 28.

PMID:
23356871
17.

Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss.

Arslan N, Oğuz H, Demirci M, Şafak MA, İslam A, Kaytez SK, Samim E.

Otol Neurotol. 2011 Apr;32(3):393-7. doi: 10.1097/MAO.0b013e318206fdfa.

PMID:
21221047
18.

Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes.

Kakehata S, Sasaki A, Oji K, Futai K, Ota S, Makinae K, Shinkawa H.

Otol Neurotol. 2006 Aug;27(5):604-8.

PMID:
16788418
19.

Evaluation of intratympanic dexamethasone for treatment of refractory sudden sensorineural hearing loss.

Wang YW, Ren JH, Lu YD, Yin TF, Xie DH.

J Zhejiang Univ Sci B. 2012 Mar;13(3):203-8. doi: 10.1631/jzus.B1100248.

20.

The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss.

Lee JB, Choi SJ, Park K, Park HY, Choo OS, Choung YH.

Eur Arch Otorhinolaryngol. 2011 Jun;268(6):833-9. doi: 10.1007/s00405-010-1476-8. Epub 2011 Jan 8.

PMID:
21221620
Items per page

Supplemental Content

Write to the Help Desk